FibroGen Announces Analysis of Peritoneal Dialysis Patients With Chronic ... 4-traders (press release) Roxadustat (FG-4592) is an orally administered small molecule inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylase activity, in development for the treatment of anemia in patients with chronic kidney disease (CKD). HIF is a protein ... FibroGen presents China-based Phase 2 study data of roxadustat for treatment ... |
